Stockscreener 앱 받기
43.87
2.62%
-1.18
시간 외 거래:
44.07
0.20
+0.46%
전일 마감가:
$45.05
열려 있는:
$44.32
하루 거래량:
15.99M
Relative Volume:
0.80
시가총액:
$63.58B
수익:
$20.62B
순이익/손실:
$3.56B
주가수익비율:
18.40
EPS:
2.3847
순현금흐름:
$3.48B
1주 성능:
-2.47%
1개월 성능:
-15.36%
6개월 성능:
-36.54%
1년 성능:
-56.07%
1일 변동 폭
$43.68
$44.99
1주일 범위
$42.78
$46.27
52주 변동 폭
$42.20
$105.65
보스턴사이언티픽 Stock (BSX) Company Profile
명칭
Boston Scientific Corp
전화
508-683-4000
주소
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
Compare BSX vs ABT, MDT, SYK, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BSX
Boston Scientific Corp
|
43.87 | 62.29B | 20.62B | 3.56B | 3.48B | 2.3847 |
ABT
Abbott Laboratories
|
102.03 | 176.41B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
93.75 | 116.35B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
281.50 | 105.70B | 25.27B | 3.34B | 4.57B | 8.6334 |
EW
Edwards Lifesciences Corp
|
85.74 | 48.63B | 6.30B | 1.07B | 1.09B | 1.8406 |
보스턴사이언티픽 Stock (BSX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-30 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2025-10-03 | 다운그레이드 | Erste Group | Buy → Hold |
| 2025-09-08 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2025-06-16 | 개시 | Leerink Partners | Outperform |
| 2025-04-16 | 업그레이드 | Needham | Hold → Buy |
| 2025-01-10 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2024-10-18 | 다운그레이드 | Needham | Buy → Hold |
| 2024-05-30 | 개시 | Goldman | Buy |
| 2024-02-01 | 업그레이드 | Mizuho | Neutral → Buy |
| 2023-07-19 | 개시 | Robert W. Baird | Outperform |
| 2023-06-30 | 개시 | CL King | Buy |
| 2023-05-30 | 재개 | Morgan Stanley | Overweight |
| 2023-03-29 | 개시 | UBS | Buy |
| 2022-12-22 | 개시 | Mizuho | Neutral |
| 2022-12-20 | 재개 | Citigroup | Buy |
| 2022-10-18 | 개시 | Barclays | Overweight |
| 2022-10-12 | 개시 | Jefferies | Buy |
| 2022-07-06 | 개시 | Wolfe Research | Outperform |
| 2022-05-27 | 업그레이드 | Needham | Hold → Buy |
| 2022-04-13 | 재개 | Truist | Buy |
| 2022-03-02 | 재개 | BofA Securities | Buy |
| 2021-12-10 | 개시 | RBC Capital Mkts | Outperform |
| 2021-05-26 | 다운그레이드 | Needham | Buy → Hold |
| 2021-05-25 | 개시 | Barclays | Overweight |
| 2021-04-15 | 개시 | Atlantic Equities | Overweight |
| 2020-09-17 | 개시 | Truist | Buy |
| 2020-09-11 | 개시 | Wolfe Research | Peer Perform |
| 2020-04-22 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-01 | 업그레이드 | Goldman | Neutral → Buy |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2020-02-13 | 개시 | Goldman | Neutral |
| 2020-02-06 | 재개 | BTIG Research | Buy |
| 2019-12-30 | 재확인 | Cowen | Outperform |
| 2019-12-19 | 다운그레이드 | Needham | Strong Buy → Buy |
| 2019-09-05 | 재개 | JP Morgan | Overweight |
| 2019-09-03 | 재개 | Barclays | Overweight |
| 2019-05-13 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2018-11-28 | 개시 | UBS | Buy |
| 2018-10-16 | 개시 | Barclays | Overweight |
| 2018-10-02 | 재확인 | Morgan Stanley | Overweight |
| 2018-09-07 | 재확인 | Needham | Strong Buy |
| 2018-09-04 | 업그레이드 | Jefferies | Hold → Buy |
| 2018-07-06 | 재확인 | Needham | Strong Buy |
| 2018-06-27 | 개시 | Bernstein | Outperform |
| 2018-04-26 | 재확인 | Needham | Strong Buy |
모두보기
보스턴사이언티픽 주식(BSX)의 최신 뉴스
Why Did BSX Cut FY26 Guidance? CEO Details Three Unanticipated Factors At Bernstein Conference - Stocktwits
Boston Scientific stock falls as cyberattack clouds 2026 outlook - ad-hoc-news.de
Is Boston Scientific (BSX) a Buy as Wall Street Analysts Look Optimistic? - Yahoo Finance
Boston Scientific fully restores operations after cyberattack - Yahoo Finance
What Is Moving the Story Around Boston Scientific (BSX)? - Kalkine Media
Why Boston Scientific (BSX) Dipped More Than Broader Market Today - Yahoo Finance
Boston Scientific Corp (BSX) Stock Down 4.1% -- Now Undervalued? GF Score: 77/100 - GuruFocus
Boston Scientific Corp. stock underperforms Thursday when compared to competitors - MarketWatch
Alpha Buying: 4 Falling Knives Insiders Are Buying - Benzinga
Boston Scientific stock falls as cyberattack clouds 2026 guidance - ad-hoc-news.de
Boston Scientific at Wells Fargo conference: cyberattack clouds outlook By Investing.com - Investing.com India
Boston Scientific at Wells Fargo conference: cyberattack clouds outlook - Investing.com
Boston Scientific Corp at Wells Fargo Healthcare Conference Transcript - GuruFocus
Update on recent cybersecurity incident - Boston Scientific
Boston Scientific stock falls as cyberattack prompts guidance cut and BTIG lowers price target - ad-hoc-news.de
Boston Scientific Flags Financial Hit From Cyberattack - BankInfoSecurity
Medtronic Is on the Cusp of Becoming a Dividend King. Is the Stock a Buy for Income Investors? - The Motley Fool
Imax To Rally More Than 23%? Here Are 10 Top Analyst Forecasts For Wednesday - Benzinga
BSX Maintains Buy Rating by BTIG -- Price Target Lowered to $56 - GuruFocus
Boston Scientific Corp. Stock Slides 5.9%, Underperforms Peers - webull.com
Boston Scientific says cyberattack likely to hurt 2026 sales, profit By Reuters - investing.com
Boston Scientific Corp (BSX) Stock Down 5.9% -- Now Undervalued? GF Score: 77/100 - GuruFocus
Boston Scientific Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
Boston Scientific says unlikely to meet 2026 sales, profit forecast after cyberattack - theinsurer.com
Boston Scientific Flags Guidance Miss Amid 'Material Impact' From Cybersecurity Incident; Shares Fall - Yahoo Finance
Boston Scientific misses 2026 guidance after cyberattack - Yahoo Finance
Boston Scientific Says Cyberattack Will Impact 2026 Results — Says It Is ‘Unlikely’ To Meet Net Sales Growth, EPS Guidance Ranges - Yahoo Finance
Boston Scientific Says It Won't Meet 2026 Guidance After Cyberattack - Benzinga
Boston Scientific stock falls after 2026 guidance cut - ad-hoc-news.de
Damages from med-tech cyberattacks adding up - BioWorld News
Boston Scientific left nursing its bottom line after cyberattack - The Register
Boston Scientific Unlikely to Meet Forecasts After Cyber Attack - Bloomberg.com
Novartis and Boston Scientific Slide, Intel Price Hikes | Stock Movers - Yahoo Finance
Boston Scientific Warns On Earnings After Cyberattack - baystreet.ca
Boston Scientific Says Cyberattack Will Hit Q3 and FY2026 Results and Miss Guidance - Minichart
Boston Scientific Shares Slide After Cyberattack Forces 2026 Guidance Cut - AskTraders
Boston Scientific's 2026 Growth Outlook Weakens: Is Recovery Ahead? - Yahoo Finance
Boston Scientific unlikely to meet guidance due to cyberattack - Yahoo Finance
TD Cowen reiterates Boston Scientific stock Buy rating after cyber recovery By Investing.com - Investing.com South Africa
Boston Scientific Unlikely to Meet Net Sales Guidance as Cybersecurity Incident Disrupts Operations - marketscreener.com
Boston Scientific CorpIdentifies Cybersecurity Incident Causing Global Operational DisruptionSEC Filing - TradingView
Boston Scientific Won't Meet Guidance Due to Cyberattack - marketscreener.com
Boston Scientific unlikely to meet Q3FY26 and full-year guidance - scanx.trade
Boston Scientific Won’t Meet Guidance Due to Cyberattack - Yahoo Finance
Why is Boston Scientific stock sliding today? - Investing.com
Why is Boston Scientific stock sliding today? By Investing.com - Investing.com UK
Boston Scientific says cyberattack likely to hurt 2026 sales, profit - marketscreener.com
Boston Scientific says cyberattack likely to hurt 2026 sales, profit targets - marketscreener.com
Cyberattack forces Boston Scientific (NYSE: BSX) to rethink its 2026 outlook - Stock Titan
TD Cowen reiterates Boston Scientific stock Buy rating after cyber recovery - Investing.com Canada
Boston Scientific on road to recovery following cyberattack - Yahoo Finance
보스턴사이언티픽 (BSX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.26%
0.28%
자본화:
|
볼륨(24시간):